See more : Rockland Resources Ltd. (RKL.CN) Income Statement Analysis – Financial Results
Complete financial analysis of MicroPort Scientific Corporation (0853.HK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of MicroPort Scientific Corporation, a leading company in the Medical – Devices industry within the Healthcare sector.
- Fortune Brands Home & Security, Inc. (FBHS) Income Statement Analysis – Financial Results
- Carrier Global Corporation (CARR) Income Statement Analysis – Financial Results
- Brookfield Asset Management Inc. (BAM-A.TO) Income Statement Analysis – Financial Results
- T-Mobile US, Inc. (TM5.DE) Income Statement Analysis – Financial Results
- Teladan Group Berhad (0230.KL) Income Statement Analysis – Financial Results
MicroPort Scientific Corporation (0853.HK)
About MicroPort Scientific Corporation
MicroPort Scientific Corporation, an investment holding company, manufactures, and markets, and distributes medical devices in the People's Republic of China, North America, Europe, other Asian countries, South America, and internationally. The company's Cardiovascular Devices segment offers products and services for the treatment of coronary artery-related diseases; coronary stents and related delivery systems; and balloon catheters and accessories. Its Orthopedics Devices segment provides reconstructive joints, spine and trauma, and other professional implants and instruments. The company's Cardiac Rhythm Management Business segment offers defibrillators, cardiac resynchronization therapy devices, and pacemakers for the diagnosis, treatment, and management of heart rhythm disorders and heart failure. Its Endovascular and Peripheral Vascular Devices segment provides products and services for the interventional treatment of thoracic and abdominal aortic aneurysm, peripheral vascular diseases, aortic dissection, and other endovascular related diseases. The company's Neurovascular Devices segment offers neurovascular therapeutic and access devices for neurovascular diseases. Its Heart Valve Business segment provides VitaFlow Transcatheter aortic valve and delivery system, VitaFlow Liberty Transcatheter aortic valve implantation and retrievable delivery systems, Alwide Plus Balloon Catheter, various transcatheter aortic valve implantation, transcatheter mitral valve, transcatheter tricuspid valve, and surgical valve products. The company's Surgical Robot Business segment designs, develops, and commercializes surgical robots comprising robot ontology, control algorithm, electrical engineering, image-based navigation, and precision imaging. Its Surgical Devices segment researches and develops, manufactures, and sells surgical devices. MicroPort Scientific Corporation was founded in 1998 and is headquartered in Shanghai, the People's Republic of China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 950.73M | 840.83M | 778.64M | 648.73M | 793.49M | 669.49M | 444.19M | 389.92M | 375.84M | 355.28M | 154.89M | 149.15M | 133.63M | 109.72M | 82.12M |
| Cost of Revenue | 418.63M | 339.06M | 286.87M | 212.70M | 229.07M | 199.47M | 125.79M | 118.24M | 123.34M | 112.00M | 29.39M | 24.53M | 21.84M | 14.81M | 11.43M |
| Gross Profit | 532.10M | 501.77M | 491.77M | 436.03M | 564.43M | 470.02M | 318.40M | 271.68M | 252.51M | 243.29M | 125.50M | 124.62M | 111.79M | 94.91M | 70.69M |
| Gross Profit Ratio | 55.97% | 59.68% | 63.16% | 67.21% | 71.13% | 70.21% | 71.68% | 69.68% | 67.18% | 68.48% | 81.02% | 83.55% | 83.66% | 86.51% | 86.08% |
| Research & Development | 379.43M | 431.02M | 297.78M | 192.63M | 151.49M | 104.81M | 58.15M | 51.90M | 60.35M | 54.56M | 29.82M | 23.37M | 24.35M | 17.77M | 12.65M |
| General & Administrative | 205.79M | 247.53M | 262.96M | 184.52M | 119.35M | 95.74M | 63.13M | 64.25M | 65.03M | 70.77M | 19.67M | 16.76M | 15.58M | 10.51M | 7.45M |
| Selling & Marketing | 334.94M | 328.23M | 297.53M | 254.11M | 275.27M | 217.79M | 137.77M | 128.46M | 127.74M | 133.63M | 26.18M | 27.72M | 24.20M | 19.46M | 14.38M |
| SG&A | 540.73M | 575.76M | 560.49M | 438.62M | 394.61M | 313.53M | 200.89M | 192.71M | 192.77M | 204.40M | 45.85M | 44.47M | 39.78M | 29.97M | 21.83M |
| Other Expenses | 128.10M | 0.00 | -27.25M | -28.08M | -6.81M | 429.00K | 402.00K | 908.00K | -427.00K | -159.00K | 194.71K | -3.02M | -6.97M | 3.97M | -2.87M |
| Operating Expenses | 1.05B | 1.03B | 831.02M | 603.17M | 539.29M | 421.67M | 256.16M | 233.98M | 246.79M | 289.13M | 93.09M | 64.83M | 57.16M | 51.70M | 31.60M |
| Cost & Expenses | 1.47B | 1.37B | 1.12B | 815.87M | 768.35M | 621.15M | 381.95M | 352.22M | 370.13M | 401.13M | 122.48M | 89.36M | 79.00M | 66.51M | 43.03M |
| Interest Income | 29.40M | 54.81M | 15.83M | 6.27M | 3.54M | 1.02M | 1.71M | 885.00K | 1.00M | 4.54M | 2.32M | 4.91M | 5.11M | 650.42K | -0.51 |
| Interest Expense | 92.73M | 73.91M | 42.71M | 37.39M | 21.33M | 19.81M | 13.21M | 15.80M | 13.11M | 12.21M | 1.08M | 183.12K | 218.93K | 612.73K | 2.51M |
| Depreciation & Amortization | 151.25M | 76.31M | 93.48M | 68.75M | 61.18M | 42.38M | 34.57M | 36.08M | 37.60M | 37.64M | 7.29M | 6.74M | 5.82M | 4.19M | 3.11M |
| EBITDA | -382.54M | -430.26M | -251.29M | -106.87M | 83.01M | 95.12M | 78.15M | 77.16M | 42.17M | -3.67M | 57.75M | 73.55M | 65.56M | 47.40M | 42.20M |
| EBITDA Ratio | -40.24% | -43.74% | -32.27% | -16.27% | 10.46% | 14.69% | 17.36% | 19.87% | 11.36% | -2.05% | 27.27% | 49.30% | 49.06% | 43.20% | 51.39% |
| Operating Income | -516.17M | -506.57M | -339.24M | -167.14M | 21.83M | 52.05M | 47.86M | 45.93M | 10.02M | -39.37M | 34.95M | 66.81M | 59.73M | 43.21M | 39.09M |
| Operating Income Ratio | -54.29% | -60.25% | -43.57% | -25.76% | 2.75% | 7.78% | 10.77% | 11.78% | 2.67% | -11.08% | 22.56% | 44.80% | 44.70% | 39.38% | 47.60% |
| Total Other Income/Expenses | -110.35M | -74.57M | -43.71M | -45.38M | 34.75M | -19.13M | -17.49M | -20.65M | -18.57M | -14.15M | -1.06M | -268.35K | -218.93K | 1.29M | -2.51M |
| Income Before Tax | -626.52M | -581.52M | -337.32M | -212.94M | 63.21M | 32.93M | 30.37M | 25.29M | -8.54M | -53.51M | 33.87M | 66.54M | 59.52M | 44.50M | 36.58M |
| Income Before Tax Ratio | -65.90% | -69.16% | -43.32% | -32.82% | 7.97% | 4.92% | 6.84% | 6.48% | -2.27% | -15.06% | 21.87% | 44.62% | 44.54% | 40.56% | 44.54% |
| Income Tax Expense | 22.64M | 6.60M | 13.97M | 10.41M | 34.20M | 14.55M | 13.42M | 10.22M | 2.84M | 6.06M | 9.36M | 9.83M | 8.46M | 8.30M | 9.28M |
| Net Income | -477.63M | -436.52M | -351.30M | -223.35M | 29.01M | 23.91M | 18.82M | 14.14M | -12.09M | -59.46M | 24.51M | 56.71M | 51.05M | 36.20M | 27.30M |
| Net Income Ratio | -50.24% | -51.91% | -45.12% | -34.43% | 3.66% | 3.57% | 4.24% | 3.63% | -3.22% | -16.74% | 15.82% | 38.02% | 38.20% | 32.99% | 33.24% |
| EPS | -0.27 | -0.24 | -0.19 | -0.13 | 0.02 | 0.02 | 0.01 | 0.01 | -0.01 | -0.04 | 0.02 | 0.04 | 0.04 | 0.03 | 0.02 |
| EPS Diluted | -0.26 | -0.25 | -0.19 | -0.12 | 0.02 | 0.02 | 0.01 | 0.01 | -0.01 | -0.04 | 0.02 | 0.04 | 0.04 | 0.03 | 0.02 |
| Weighted Avg Shares Out | 1.76B | 1.81B | 1.81B | 1.74B | 1.67B | 1.56B | 1.43B | 1.42B | 1.42B | 1.41B | 1.40B | 1.41B | 1.44B | 1.22B | 1.13B |
| Weighted Avg Shares Out (Dil) | 1.82B | 1.82B | 1.81B | 1.80B | 1.67B | 1.56B | 1.47B | 1.44B | 1.42B | 1.45B | 1.43B | 1.44B | 1.46B | 1.22B | 1.14B |
Source: https://incomestatements.info
Category: Stock Reports